These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9804842)

  • 1. Overexpression of branched O-linked oligosaccharides on T cell surface glycoproteins impairs humoral immune responses in transgenic mice.
    Tsuboi S; Fukuda M
    J Biol Chem; 1998 Nov; 273(46):30680-7. PubMed ID: 9804842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Branched O-linked oligosaccharides ectopically expressed in transgenic mice reduce primary T-cell immune responses.
    Tsuboi S; Fukuda M
    EMBO J; 1997 Nov; 16(21):6364-73. PubMed ID: 9351819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a differentiation antigen and poly-N-acetyllactosaminyl O-glycans directed by a cloned core 2 beta-1,6-N-acetylglucosaminyltransferase.
    Bierhuizen MF; Maemura K; Fukuda M
    J Biol Chem; 1994 Feb; 269(6):4473-9. PubMed ID: 8308016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Golgi localization of core 2 beta-1,6-N-acetylglucosaminyltransferase leads to decreased synthesis of branched O-glycans.
    Skrincosky D; Kain R; El-Battari A; Exner M; Kerjaschki D; Fukuda M
    J Biol Chem; 1997 Sep; 272(36):22695-702. PubMed ID: 9278427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivalent, but not divalent, antigen receptor cross-linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells. A redefinition of the TI-2 vs T cell-dependent antigen dichotomy.
    Snapper CM; Kehry MR; Castle BE; Mond JJ
    J Immunol; 1995 Feb; 154(3):1177-87. PubMed ID: 7529792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
    Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
    J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.
    Foy TM; Shepherd DM; Durie FH; Aruffo A; Ledbetter JA; Noelle RJ
    J Exp Med; 1993 Nov; 178(5):1567-75. PubMed ID: 7693850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/CD40 ligand.
    Chen FA; Williams SS; Fanslow WC; Bankert RB
    J Immunol; 1995 Sep; 155(6):2833-40. PubMed ID: 7673699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of O-linked oligosaccharides in immune responses.
    Tsuboi S; Fukuda M
    Bioessays; 2001 Jan; 23(1):46-53. PubMed ID: 11135308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of p190RhoGEF enhances B-cell activation and germinal center formation in T-cell-dependent humoral immune responses.
    Jeong JH; Ha YJ; Choi SY; Kim JH; Yun Y; Lee JR
    Immunol Cell Biol; 2019 Nov; 97(10):877-887. PubMed ID: 31361349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functions of CD40 and Its Ligand, gp39 (CD40L).
    Laman JD; Claassen E; Noelle RJ
    Crit Rev Immunol; 2017; 37(2-6):371-420. PubMed ID: 29773027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucin-type O-glycans and leukosialin.
    Fukuda M; Tsuboi S
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):205-17. PubMed ID: 10571013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 ligand/CD40 deficiency.
    Castigli E; Fuleihan R; Ramesh N; Tsitsikov E; Tsytsykova A; Geha RS
    Int Arch Allergy Immunol; 1995; 107(1-3):37-9. PubMed ID: 7542090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The superantigen toxic shock syndrome toxin-1 induces CD40 ligand expression and modulates IgE isotype switching.
    Jabara HH; Geha RS
    Int Immunol; 1996 Oct; 8(10):1503-10. PubMed ID: 8921429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
    Van den Eertwegh AJ; Noelle RJ; Roy M; Shepherd DM; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
    J Exp Med; 1993 Nov; 178(5):1555-65. PubMed ID: 7693849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation.
    Kawabe T; Naka T; Yoshida K; Tanaka T; Fujiwara H; Suematsu S; Yoshida N; Kishimoto T; Kikutani H
    Immunity; 1994 Jun; 1(3):167-78. PubMed ID: 7534202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cells.
    Aversa G; Punnonen J; Carballido JM; Cocks BG; de Vries JE
    Semin Immunol; 1994 Oct; 6(5):295-301. PubMed ID: 7532459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome.
    Higgins EA; Siminovitch KA; Zhuang DL; Brockhausen I; Dennis JW
    J Biol Chem; 1991 Apr; 266(10):6280-90. PubMed ID: 2007580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell immunopoiesis: visualizing the impact of CD40 engagement on the course of T cell-independent immune responses in an Ig transgenic system.
    Erickson LD; Vogel LA; Cascalho M; Wong J; Wabl M; Durell BG; Noelle RJ
    Eur J Immunol; 2000 Nov; 30(11):3121-31. PubMed ID: 11093126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions.
    Maruo S; Oh-hora M; Ahn HJ; Ono S; Wysocka M; Kaneko Y; Yagita H; Okumura K; Kikutani H; Kishimoto T; Kobayashi M; Hamaoka T; Trinchieri G; Fujiwara H
    J Immunol; 1997 Jan; 158(1):120-6. PubMed ID: 8977182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.